Brian Fagioli

Bristol Myers Squibb plans NVIDIA DGX SuperPOD for drug discovery

Bristol Myers Squibb plans NVIDIA DGX SuperPOD for drug discovery

Bristol Myers Squibb is expanding its NVIDIA infrastructure with a Vera Rubin AI factory designed to support drug discovery, proprietary models, and AI-powered scientific research.

ReliaQuest is putting OpenAI deeper inside enterprise cyber defense

ReliaQuest is putting OpenAI deeper inside enterprise cyber defense

ReliaQuest is joining OpenAI’s Daybreak Cyber Partner Program to bring more advanced AI capabilities into GreyMatter. The partnership could speed up security investigations, but ReliaQuest has not yet revealed specific features, launch timing, or customer results.

1Password lets Claude use your passwords without seeing them, and that is safer than it sounds

1Password lets Claude use your passwords without seeing them, and that is safer than it sounds

1Password for Claude allows the AI agent to use approved credentials without seeing the password. The system is safer than it sounds, but authenticated access still carries serious risks.